Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial

Joseph P. Casazza, Maria Claudia Burgos Florez, Anita Arthur et al.|Nature Medicine|2022

Cited by 94